Is Your Dry Eye More Than Just Dryness? The Surprising Link Between Dry Eyes, ADHD, and Depression
"New research reveals how dry eye disease can be connected to mental health, impacting both diagnosis and treatment."
Dry eye disease (DED) is a widespread condition affecting millions, characterized by discomfort, visual disturbances, and tear film instability. While often viewed as a purely physical ailment, emerging research suggests a deeper connection to mental health, particularly depression and ADHD. This challenges traditional approaches, highlighting the need for a more holistic perspective.
Traditionally, diagnosis relies on symptom reporting and clinical examinations. However, these subjective experiences don't always align. This inconsistency underscores the complexity of DED and prompts further investigation into underlying factors, including psychological conditions.
Recent studies have started to uncover significant correlations between dry eye disease and various psychiatric symptoms. This article explores these connections, drawing from a study examining the prevalence of depression, anxiety, ADHD, job stress, and sleep problems in individuals with dry eye disease. We'll delve into the implications and explore how this knowledge can lead to better diagnosis and more comprehensive treatment strategies.
The Scale of the Problem
Dry eye disease affects an estimated 16 million diagnosed Americans, with many more suffering undiagnosed symptoms, and its prevalence continues to rise as a public health concern. In parallel, approximately 7 million U.S. children aged 3–17 years have a current ADHD diagnosis as of 2024 data. The National Eye Institute and CDC's Vision and Eye Health Surveillance System provide ongoing tracking of vision loss and eye disorders across the population. These converging epidemics—chronic ocular surface disease and neurodevelopmental conditions—share overlapping patient populations that are only now being systematically studied.
Current Treatment Paradigms and Gaps
The standard diagnostic and therapeutic approach to dry eye disease typically begins with preservative-free artificial tears and progresses to anti-inflammatory agents, with specialized corneal and ocular surface care reserved for severe or chronic cases. The American Academy of Ophthalmology's 2023 Preferred Practice Pattern guidelines represent the evidence-based baseline for clinical management. However, leading experts acknowledge that current therapies have significant limitations, particularly for patients whose dry eye does not respond adequately to conventional treatment. Pediatric dry eye disease presents additional unique challenges compared to adult manifestation, necessitating tailored approaches that account for distinct developmental needs.
How We Got Here: Parallel Histories
Dry eye disease has been recognized as one of the most common ocular surface disorders, with its modern understanding captured across seven thematic areas including tear film structure and ocular surface function. ADHD's history stretches back to the early 1900s, when it was first scientifically defined as a deficit of moral control before evolving into a recognized neurodevelopmental condition with defined diagnostic criteria and medications. Both conditions have undergone significant conceptual shifts—dry eye from a simple lubrication problem to a complex neuroimmune disorder, and ADHD from a behavioral issue to a neurobiological condition. These parallel evolutions in medical understanding have set the stage for recognizing unexpected connections between the two.
The Surprising Connection: Dry Eyes, ADHD, and Mental Well-being
A groundbreaking study conducted in Korea sheds light on the intricate relationship between dry eye disease and mental health. Researchers compared individuals experiencing dry eye symptoms with a control group to assess differences in depression, anxiety, ADHD, job stress, and sleep problems. The findings revealed a significant association between dry eye disease and these psychological factors, suggesting a more complex interplay than previously understood.
- Ocular Surface Disease Index (OSDI): Indicating greater discomfort and functional limitations related to dry eye symptoms.
- Center for Epidemiological Studies-Depression Scale (CES-D): Suggesting a higher prevalence of depressive symptoms.
- Korean Adult Attention Deficit Hyperactivity Disorder Scales (K-AADHS): Highlighting a potential link between dry eye disease and ADHD.
- Korean version of Pittsburgh Sleep Quality Index (PSQI-K): Implying poorer sleep quality among individuals with dry eye disease.
Emerging Evidence: The Brain-Eye Connection
A 2026 systematic review published in Frontiers in Medicine found that personality traits may influence dry eye disease symptom perception, disease course, and patients' psychological adjustment, suggesting subjective symptoms could be shaped by stable individual characteristics. Research on diabetic dry eye has advanced understanding of mechanism-based treatments, with reviews emphasizing the need for precision therapy approaches. A 2024 study in the American Journal of Ophthalmology documented associations between dry eye disease and mental health conditions, finding that the approximately 6–8% of U.S. adults with DED often experience chronic irritation that negatively affects daily function. A 2025 MDPI review characterized dry eye as a systemic, neuroimmune-driven disorder with strong psychiatric interplay, calling for integrated multidisciplinary approaches bridging ophthalmology and psychiatry.
Skepticism and Unresolved Questions
While the associations between dry eye disease and psychiatric conditions are increasingly documented, establishing definitive causal pathways remains challenging. Correlation between these conditions does not necessarily imply causation—shared inflammatory or neuroimmune mechanisms could independently drive both, or confounding factors such as screen time, medication side effects, or socioeconomic status may explain overlapping prevalence. Some researchers caution that attributing dry eye symptoms primarily to psychological factors risks overlooking treatable ocular surface pathology. The field lacks large-scale longitudinal studies that could definitively establish whether treating one condition meaningfully improves the other.
Where Dry Eye, ADHD, and Treatment Intersect
ADHD and vision disorders share pathogenic and behavioral links that extend beyond simple coincidence. A 2024 study reviewed ADHD patients receiving methylphenidate and found associations with ocular surface disease, suggesting that ADHD medication itself may contribute to dry eye symptoms in some patients. Community reports from patients on stimulant medications like Vyvanse describe dry and occasionally red eyes as a recognized but lesser-known side effect confirmed by their physicians. Meanwhile, alternative therapies for dry eye disease are expanding beyond traditional approaches, with comprehensive ocular examinations needed to identify each patient's multiple underlying disease contributors.
A Holistic Approach to Dry Eye Treatment
Given the strong associations between dry eye disease and mental health challenges, a holistic approach to treatment is essential. Addressing both the physical and psychological aspects of the condition can lead to better outcomes and improved quality of life. It highlights the need for collaborative care, involving ophthalmologists and mental health professionals.
Expert Perspectives on Integrated Care
A 2022 systematic review in SAGE journals examined the prevalence and correlations of depression and anxiety with dry eye signs and symptoms, finding consistent associations across studies. Expert surveys have identified a growing range of treatments beyond traditional preservative-free artificial tears, reflecting the field's recognition that single-modality approaches are insufficient. A 2025 comprehensive review in Clinical Ophthalmology detailed DED's wide-ranging causes, diagnostic tests, and medical management strategies. Research published in Molecular Psychiatry in 2022 found that ADHD was associated with increased risk of disorders related to atypical corneal curvature and eye shape, though the mechanism remains under investigation.
What's Next: Innovation on the Horizon
The global dry eye disease market was valued at approximately USD 7.33 billion in 2024 and is projected to reach around USD 13 billion, reflecting both growing prevalence and expanding treatment options. For 2026, optometry leaders predict significant advancements in dry eye technology, artificial intelligence applications, and glaucoma management. The 2026 Dry Eye Report from Eyes on Eyecare highlights current trends and effective methods used by optometrists for diagnosing, treating, and managing the condition. Market analysts anticipate steady growth driven by increasing incidence, new mechanism-based therapies, and greater awareness of the systemic connections underlying ocular surface disease.
Systemic Barriers to Better Care
Despite growing evidence linking ocular surface disease to neurodevelopmental and psychiatric conditions, clinical practice has been slow to adopt integrated screening approaches. Most eye care and mental health professionals operate in silos, with limited cross-referral systems or shared diagnostic frameworks. The underrecognition of dry eye—particularly in younger populations where ADHD is more commonly diagnosed—means many patients may be suffering from untreated ocular surface disease alongside their primary psychiatric or developmental condition. Addressing these systemic gaps will require both technological innovation and fundamental changes in how multidisciplinary care is structured and delivered.
Living With Overlapping Conditions
A 2026 study in Eye found significant associations between eye disorders and subsequent development of ADHD, noting that visual impairment can impair a child's development and daily functioning. Real-world registry data from 2025 evaluated the quality-of-life impact of dry eye disease, finding that chronic ocular irritation substantially affects patients' day-to-day function and overall wellbeing. ADHD case studies reveal the complex interplay between neurodevelopmental symptoms, treatment adherence, and comorbid conditions that affect quality of life. Together, these findings underscore that for many patients, dry eye is not merely an isolated ocular complaint but part of a broader pattern of interconnected health challenges that demand holistic, patient-centered care.